Quality of Life in Patients with Sarcopenia: A Study of Prevalence and Associated Factors in Western Greek Population.

M Tsekoura, E Nomikou, A Kastrinis, E Trachani, E Billis

Abstract read

In one paragraph

Article in Advances in experimental medicine and biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it

0cells of the map it votes in

0citing papers in PubMed

–field-weighted citation impact

1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors.

M TsekouraLaboratory of Clinical Physiotherapy and Research, Department of Physiotherapy, University of Patras, Rio, Greece. mariatsekoura@upatras.gr.

E NomikouDepartment of Physiotherapy, University of West Attica, Athens, Greece.

A KastrinisDepartment of Physiotherapy, University of Thessaly, Lamia, Greece.

E TrachaniLaboratory of Clinical Physiotherapy and Research, Department of Physiotherapy, University of Patras, Rio, Greece.

E BillisLaboratory of Clinical Physiotherapy and Research, Department of Physiotherapy, University of Patras, Rio, Greece.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The objective of this study was to evaluate the quality of life (QoL) and to determine the associated factors for sarcopenia in Greek community-dwelling older adults, diagnosed according to EWGSOP2 criteria. A cross-sectional study involving older-adult participants >60 years of age was performed. QoL was assessed using the validated Greek version of the SarQoL questionnaire. Body composition was determined by bioelectrical impedance analysis, and strength assessment was performed via hand-held grip strength. Functional assessments included four-meter (4 m), and Τimed-Up and Go (TUG) test. Participants were 203 community-dwelling older adults, with a mean age of 71.4 ± 8.1 years. The prevalence of sarcopenia was 24.6% (n = 17). Sarcopenic individuals have had significantly lower scores in SarQoL. The findings of this study demonstrated that QoL in patients with sarcopenia was associated with falls and BMI. QoL has significant associations with sarcopenia in Greek older adults. In conclusion, a significantly lower QoL was noted for sarcopenic individuals compared with non-sarcopenic ones. Therefore, appropriate assessments and interventions are needed following evaluation of sarcopenia and QoL among older people.

Indexed as

Quality of LifeSarcopeniaAgedAged, 80 and overBody CompositionBody Mass IndexCross-Sectional StudiesFemaleGeriatric AssessmentGreeceHand StrengthHumansIndependent LivingMaleMiddle AgedPrevalenceOlder adultsQuality of lifeSarcopenia

Identifiers

PMID41251997

DOI10.1016/j.metabol.2023.155533

What OpenQuestion holds

Textmetadata

Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.